Table 3.
Odds of presence of CIN at 9-month follow-up for HIV+ women assigned to the 10-week cognitive behavioral stress management (CBSM) group.
| Wald Statistic |
Odds Ratio |
95% Confidence Interval for Odds Ratio |
p-value | |||
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| Step 1. Biobehavioral variables | ||||||
| Presence of CIN at study entry | .87 | 4.33 | .20 | 93.96 | .35 | |
| Presence of HR-HPV types at study entry | .45 | 2.14 | .23 | 19.96 | .51 | |
| Change in CD4+CD3+ cell count (cells/mm3) from study entry to 9-month follow-up | 1.81 | 1.00 | .99 | 1.00 | .18 | |
| Pack years of cigarette smoking at study entry | .05 | 1.00 | 1.00 | 1.00 | .83 | |
| HIV viral load (copies/mL) at study entry (log10 transformed) | .32 | 1.27 | .56 | 2.86 | .58 | |
| Step 2. Experimental condition | ||||||
| Assignment to 10-week CBSM group | 4.94 | .05 | .003 | .70 | .03 | |
Note. HR-HPV = High-Risk Human Papillomavirus. Significance of overall model, χ2 (6) = 14.52, p = .03.